Close Menu

Stelis is a fully integrated, global biopharmaceutical company committed to making biological treatments accessible to patients globally.

Our hybrid business model comprises the development, manufacture and commercialization of products targeted against large treatment markets that are currently underserved and the provision of state-of-the-art Contract Development and Manufacturing services to global companies by means of our CDMO division,

Our products include differentiated biosimilars, novel biologics and other complex large molecules. Stelis operates research, development and cGMP manufacturing out of Bangalore, India with the aim of bringing world-class treatments at affordable cost to patients in both emerging and developed markets.

Read more

About Us

Stelis Biopharma Pvt. Ltd. (Stelis) was started in 2013 by Strides Pharma Science Limited (Strides) to drive a global affordable biopharma business. Via on-going investment, Strides remains a majority owner of Stelis alongside GMS Holdings and Tenshi Life Sciences. It continues to operate as an independent and autonomous subsidiary company.

Visit our About Us page to read more about our core values and leadership team.

Read more


A Global CDMO in the Making

Read more

Strides Board Approves Incremental Investments in Stelis

Read more

Next Event

No upcoming events. Please check back soon.